Philip R. Harper, 10% Owner at Aevi Genomic Medicine, Inc. (GNMC), bought 83,775 shares at $1.20 ($101K) on 2017-09-01, disclosed to the SEC on 2017-09-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| GNMX | BUY | 2017-03-27 | $2.0M | — | Filing → |
| ACAS | SELL | 2015-12-04 | $1.1M | — | Filing → |
| ACAS | SELL | 2015-03-13 | $577K | — | Filing → |